Omlyclo savings card: as little as $0 a dose with commercial insurance

How to pay the least

Ask for the cash price

Omlyclo

Omlyclo is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

Ask your pharmacy for Omlyclo’s cash price, and one or two other pharmacies too.
Omlyclo’s savings card works only with insurance from a job or one you bought.

Compare every option

Brand nameOmlyclo

Authorized genericomalizumab-igec

Regular genericomalizumab-igec

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldAsk the pharmacy

Same as Omlyclo?

The original

–

Brand nameThe maker’s card

Celltrion CARES Co-pay Program

Savings card from Celltrion

No insuranceNeeds insuranceNo cash price listed.

Insurance · as little as $0 a dose

In the maker’s words

“Eligible patients may pay as little as $0 out of pocket for each dose…”

From the maker’s offer on omlyclo.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Omlyclo itself, from the same company, sold without the brand name, and usually for less. For now Omlyclo is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Omlyclo is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

OMLYCLO is an anti-IgE antibody indicated for:

Moderate to severe persistent asthma in adults and pediatric patients 6 years of age and older with a positive skin test or in vitro reactivity to a perennial aeroallergen and symptoms that are inadequately controlled with inhaled corticosteroids
Chronic rhinosinusitis with nasal polyps (CRSwNP) in adult patients 18 years of age and older with inadequate response to nasal corticosteroids, as add-on maintenance treatment
IgE-mediated food allergy in adult and pediatric patients aged 1 year and older for the reduction of allergic reactions (Type I), including anaphylaxis, that may occur with accidental exposure to one or more foods. To be used in conjunction with food allergen avoidance
Chronic spontaneous urticaria (CSU) in adults and adolescents 12 years of age and older who remain symptomatic despite H1 antihistamine treatment

Limitations of Use:

Not indicated for acute bronchospasm or status asthmaticus.
Not indicated for the emergency treatment of allergic reactions, including anaphylaxis
Not indicated for other forms of urticaria.

Source: the FDA label for Omlyclo (CELLTRION USA, Inc.), October 6, 2026. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/omlyclo/